ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.


Journal

Endoscopy
ISSN: 1438-8812
Titre abrégé: Endoscopy
Pays: Germany
ID NLM: 0215166

Informations de publication

Date de publication:
02 2020
Historique:
pubmed: 22 12 2019
medline: 16 2 2021
entrez: 22 12 2019
Statut: ppublish

Résumé

1:  ESGE recommends routine rectal administration of 100 mg of diclofenac or indomethacin immediately before endoscopic retrograde cholangiopancreatography (ERCP) in all patients without contraindications to nonsteroidal anti-inflammatory drug administration.Strong recommendation, moderate quality evidence. 2:  ESGE recommends prophylactic pancreatic stenting in selected patients at high risk for post-ERCP pancreatitis (inadvertent guidewire insertion/opacification of the pancreatic duct, double-guidewire cannulation).Strong recommendation, moderate quality evidence. 3:  ESGE suggests against routine endoscopic biliary sphincterotomy before the insertion of a single plastic stent or an uncovered/partially covered self-expandable metal stent for relief of biliary obstruction.Weak recommendation, moderate quality evidence. 4:  ESGE recommends against the routine use of antibiotic prophylaxis before ERCP.Strong recommendation, moderate quality evidence. 5:  ESGE suggests antibiotic prophylaxis before ERCP in the case of anticipated incomplete biliary drainage, for severely immunocompromised patients, and when performing cholangioscopy.Weak recommendation, moderate quality evidence. 6:  ESGE suggests tests of coagulation are not routinely required prior to ERCP for patients who are not on anticoagulants and not jaundiced.Weak recommendation, low quality evidence. 7:  ESGE suggests against salvage pancreatic stenting in patients with post-ERCP pancreatitis.Weak recommendation, low quality evidence. 8:  ESGE suggests temporary placement of a biliary fully covered self-expandable metal stent for post-sphincterotomy bleeding refractory to standard hemostatic modalities.Weak recommendation, low quality evidence. 9:  ESGE suggests to evaluate patients with post-ERCP cholangitis by abdominal ultrasonography or computed tomography (CT) scan and, in the absence of improvement with conservative therapy, to consider repeat ERCP. A bile sample should be collected for microbiological examination during repeat ERCP.Weak recommendation, low quality evidence.

Identifiants

pubmed: 31863440
doi: 10.1055/a-1075-4080
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

127-149

Informations de copyright

© Georg Thieme Verlag KG Stuttgart · New York.

Déclaration de conflit d'intérêts

T. Beyna receives consultancy fees from Olympus, Boston Scientific, and Cook (ongoing), and lecture fees from Olympus, Boston Scientific, and Medtronic (ongoing). M. Dinis-Ribeiro receives a fee as Co-Editor-in-Chief of Endoscopy journal. I. Hritz has provided consultancy and training for Olympus (2017 to present), and consultancy for Pentax Medical (2018). I. Papanikolaou has provided consultancy for Boston Scientific (25 April and 21 March, 2018). A. Tringali provided consultancy for Boston Scientific (3 April 2019); he has received publication fees from

Auteurs

Jean-Marc Dumonceau (JM)

Gastroenterology Service, Hôpital Civil Marie Curie, Charleroi, Belgium.

Christine Kapral (C)

Department of Gastroenterology and Hepatology, Ordensklinikum Barmherzige Schwestern, Linz, Austria.

Lars Aabakken (L)

GI Endoscopy Unit, OUS, Rikshospitalet University Hospital, Oslo, Norway.

Ioannis S Papanikolaou (IS)

Hepatogastroenterology Unit, Second Department of Internal Medicine - Propaedeutic, Research Institute and Diabetes Center, Medical School, National and Kapodistrian University, Attikon University General Hospital, Athens, Greece.

Andrea Tringali (A)

Digestive Endoscopy Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Centre for Endoscopic Research, Therapeutics and Training (CERTT), Università Cattolica del Sacro Cuore, Rome, Italy.

Geoffroy Vanbiervliet (G)

Centre Hospitalier Universitaire de Nice, Pole D.A.R.E, Endoscopie Digestive, Nice, France.

Torsten Beyna (T)

Department of Internal Medicine and Gastroenterology, Evangelisches Krankenhaus Düsseldorf, Dusseldorf, Germany.

Mario Dinis-Ribeiro (M)

Gastroenterology Department, Portuguese Oncology Institute of Porto, Portugal.
Center for Research in Health Technologies and Information Systems (CINTESIS), Faculty of Medicine, Porto, Portugal.

Istvan Hritz (I)

Semmelweis University, 1st Department of Surgery, Center for Therapeutic Endoscopy, Budapest, Hungary.

Alberto Mariani (A)

Division of Pancreato-Biliary Endoscopy and Endosonography, Pancreas Translational & Clinical Research Center, San Raffaele Scientific Institute IRCCS, Vita Salute San Raffaele University, Milan, Italy.

Gregorios Paspatis (G)

Gastroenterology Department, Benizelion General Hospital, Heraklion, Crete, Greece.

Franco Radaelli (F)

Gastroenterology Department, Valduce Hospital, Como, Italy.

Sundeep Lakhtakia (S)

Asian Institute of Gastroenterology, Hyderabad, India.

Andrew M Veitch (AM)

Department of Gastroenterology, New Cross Hospital, Wolverhampton, UK.

Jeanin E van Hooft (JE)

Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, University of Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH